Advanced Enzyme Technologies Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

310.40 +5.15 (1.69%)Updated : 12 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	478.99	469.46	419.71	362.90
Other Net	6.09	14.17	22.93	4.57
Diluted Weighted Average Shares	11.20	11.19	11.18	11.19
Gain( Loss)on Saleof Assets	0.23	-0.31	-0.75	1.15
Depreciation/ Amortization	36.56	35.24	35.03	34.98
Operating Income	157.92	154.41	120.93	166.48
Net Income	131.12	133.31	105.64	119.58
Income Availableto Com Excl Extra Ord	131.12	133.31	105.64	119.58
Other Operating Expenses Total	8.45	-	-	5.81
Net Income Before Taxes	187.36	187.82	140.39	171.06
Minority Interest	-2.86	-3.65	1.77	-4.22
Net Income After Taxes	133.97	136.95	103.87	123.80
Income Availableto Com Incl Extra Ord	131.12	133.31	105.64	119.58
Costof Revenue Total	202.24	199.75	180.44	148.89
Gross Profit	434.67	424.12	360.20	380.49
Interest Inc( Exp) Net- Non- Op Total	23.13	19.55	-2.72	-1.15
Unusual Expense( Income)	0.00	15.13	4.75	0.00
Diluted Net Income	131.12	133.31	105.64	119.58
DPS- Common Stock Primary Issue	5.20	5.10	1.00	1.00
Provisionfor Income Taxes	53.39	50.87	36.52	47.26
period Type	-	-	-	-
Net Income Before Extra Items	131.12	133.31	105.64	119.58
Total Revenue	636.91	623.87	540.64	529.38
period Length	12.00	12.00	12.00	12.00
Revenue	636.91	623.87	540.64	529.38
Selling/ General/ Admin Expenses Total	230.87	218.53	198.68	172.56
Diluted Normalized EPS	11.69	12.92	9.81	10.62
Research Development	0.88	0.81	0.81	0.65
Diluted EPS Excluding Extra Ord Items	11.71	11.92	9.45	10.69

*All figures in crores except per share values

Trending Stocks

171.85+5.50(3.31%)

297.90+6.80(2.34%)

11,723.00+255.95(2.23%)

2,262.65-42.05 (-1.82%)

1,794.75-12.15 (-0.67%)

Related News